Clinical Trial Update: Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Adenovirus-specific cytotoxic T-lymphocytes for refractory Adenovirus infection in patients with primary immunodeficiency is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Immunodeficiency

Drugs mentioned

• Adenovirus-specific Cytotoxic T-lymphocytes

Snippet

Sponsor: New York Medical College | Conditions: Adenovirus, Primary Immune Deficiency Disorder | Phase 2 | Status: RECRUITING